Illumina | ILMN - Net Income


Illumina reported $134M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
Bruker USD 3.5M 22.5M Mar/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -10M 136M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Illumina USD 134M 200M Mar/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
IQVIA Holdings USD 274M 240M Mar/2026
Laboratory Of America USD 277.8M 113.1M Mar/2026
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Quidel USD -91.8M 38.9M Mar/2026
Repligen USD 8.33M 4.95M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Standard Biotools USD 127.07M 107.78M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD -72M 297.21M Mar/2026